Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization

Biological Psychiatry

Volumn 48, Issue 4, 2000, Pages 330-333

  Müller, Marianne B ^a   Landgraf, Rainer ^a   Keck, Martin E ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anxiety; CRH; Esthesioneuroblastoma; HPA system; Major depression; Vasopressin

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; VASOPRESSIN;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CANCER SURGERY; CASE REPORT; DEPRESSION; DESENSITIZATION; ESTHESIONEUROBLASTOMA; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; VASOPRESSIN BLOOD LEVEL;

ADRENOCORTICOTROPIC HORMONE; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; ESTHESIONEUROBLASTOMA, OLFACTORY; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; VASOPRESSINS;

EID: 0343007403     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00886-6     Document Type: Article

References (16)

1. Antoni F.A. Vasopressinergic control of pituitary-adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 14:1993;76-122.
2. Broich G., Pagliari A., Ottaviani F. Esthesioneuroblastoma A general review of the cases published since the discovery of the tumour in 1924 . Anticancer Res. 17:1997;2683-2706.
3. de Goeij D.C.E., Dijkstra H., Tilders F.J.H. Chronic psychological stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats Relationship to subordinate status . Endocrinology. 131:1992;847-853.
4. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test a refined laboratory test for psychiatric disorders . J Psychiatr Res. 28:1994;341-356.
5. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev. 17:1996;187-205.
6. Kalsbeek A., Buijs R.M., van Heerikhuize J.J., Arts M., van der Woude T.P. Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 580:1992;62-67.
7. Kiss J.Z., Mezey E., Skirboll L. Corticotropin-releasing factor immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci U S A. 84:1984;1854-1858.
8. Landgraf R., Gerstberger R., Montkowski A., Probst J.C., Wotjak C.T., Holsboer F., et al. Release of vasopressin and oxytocin within the brain and into blood microdialysis and antisense targeting . Saito T., Kurakowa K., Yoshida S. Neurohypophysis Recent Progress of Vasopressin and Oxytocin Research . 1995;243-256 Elsevier, Amsterdam.
9. Landgraf R., Gerstberger R., Montkowski A., Probst J.C., Wotjak C.T., Holsboer F., et al. V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J Neurosci. 15:1995;4250-4258.
10. Purba J.S., Hoogendijk W.J.G., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 53:1996;137-143.
11. Raadsheer F.C., Hoogendijk W.J.G., Stam F.C., Tilders F.J.H., Swaab D.F. Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
12. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J.G., Tilders F.J.H., Swaab D.F. Corticotropin-releasing hormone levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry. 152:1995;1372-1376.
13. Tizabi Y., Aguilera G. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin. Neuroendocrinology. 56:1992;611-618.
14. van Londen L., Goekoop J.G., van Kempen G.M.J., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology. 17:1997;284-292.
15. von Bardeleben U., Holsboer F., Stalla G.K., Müller O.A. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 37:1985;1613-1618.
16. Wotjak C.T., Kubota M., Liebsch G., Montkowski A., Holsboer F., Neumann I., et al. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress A novel mechanism of regulating adrenocorticotropin secretion? J Neurosci. 16:1996;7725-7732.